Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
WINNERSH, England, Dec. 11 /PRNewswire-FirstCall/ -- Vernalis plc (LSE: VERLSE:Nasdaq:LSE:VNLS) today announced that it has started a Phase I...
WINNERSH, England, Nov. 21 /PRNewswire-FirstCall/ -- Vernalis plc (LSE: VER)(NASDAQ:VNLS), a specialty bio-pharmaceutical and drug development...
WINNERSH, England, Nov. 20 /PRNewswire-FirstCall/ -- Vernalis plc (LSE:VERLSE:Nasdaq:LSE:VNLS), a specialty bio-pharmaceutical and drug...
WINNERSH, England, Nov. 2 /PRNewswire/ -- Vernalis plc (LSE:VERLSE:Nasdaq:LSE:VNLS), a specialty bio-pharmaceutical and drug development...
WINNERSH, U.K., Sept. 20 /PRNewswire-FirstCall/ -- Vernalis plc (LSE:VER) (NASDAQ:VNLS), a specialty bio-pharmaceutical and drug development...
WINNERSH, England, Sept. 20 /PRNewswire-FirstCall/ -- Vernalis plc (LSE:VERLSE:Nasdaq:LSE:VNLS) today announced that the U.S. Food and Drug...
- Vernalis Delivers on Significant Clinical Milestones and Establishes Commercial Operation - WINNERSH, England, Sept. 12 /PRNewswire-FirstCall/...
CHADDS FORD, Pa. and WINNERSH, U.K., July 19 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP) and Vernalis plc...
WINNERSH, England, June 19 /PRNewswire-FirstCall/ -- Vernalis plc (NASDAQ:VNLS)(LSE:VER), a specialty bio-pharmaceutical and drug development...
NEW YORK, May 17 /PRNewswire-FirstCall/ -- The following is being issued by NASDAQ (NASDAQ:NDAQ): What: Simon Sturge, CEO of Vernalis plc...
Company Celebrates Significant Clinical Milestone WINNERSH, England, May 15 /PRNewswire-FirstCall/ -- Vernalis plc (LSE: VERLSE:Nasdaq:LSE:VNLS...
- Data to be Included as Part of Supplemental NDA to FDA - WINNERSH, England and CHADDS FORD, Pa., May 8 /PRNewswire-FirstCall/ -- Vernalis plc...
Endo Licenses Rights from Vernalis to Market Acute Migraine Treatment Frova(TM) CHADDS FORD, Pa., July 14 /PRNewswire-FirstCall/ -- Endo...
Vernalis Regains Control of North American Rights To Frovatriptan From Elan LONDON, March 30 /PRNewswire-FirstCall/ -- Highlights...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지